201 related articles for article (PubMed ID: 31641970)
1. Pathology of prolactinomas: any predictive value?
Lopes MBS
Pituitary; 2020 Feb; 23(1):3-8. PubMed ID: 31641970
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) and prolactin (PRL) gene expression and immunoreactivity in GH- and PRL-producing human pituitary adenomas.
Li J; Stefaneanu L; Kovacs K; Horvath E; Smyth HS
Virchows Arch A Pathol Anat Histopathol; 1993; 422(3):193-201. PubMed ID: 8493775
[TBL] [Abstract][Full Text] [Related]
3. Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.
Colao A; Ferone D; Lastoria S; Cerbone G; Di Sarno A; Di Somma C; Lucci R; Lombardi G
Clin Endocrinol (Oxf); 2000 Apr; 52(4):437-45. PubMed ID: 10762286
[TBL] [Abstract][Full Text] [Related]
4. Clinical and epidemiological characteristics of pituitary tumours in a single centre in Saudi Arabia.
Hussein SH; Wahedi TS; Johani NA; Hakami YA; Alzahrani K; AlMalki MH
Hormones (Athens); 2018 Jun; 17(2):261-267. PubMed ID: 29858852
[TBL] [Abstract][Full Text] [Related]
5. A clinicomorphological study of pituitary tumors associated with the clinical syndrome of acromegaly.
Andreeva M; Georgiev T; Bosadjieva E; Karagiosov L; Karagiosov K; Tomova A; Matrosov P; Kirilov G; Diankov L; Christova T
Exp Clin Endocrinol; 1991; 98(3):223-7. PubMed ID: 1778242
[TBL] [Abstract][Full Text] [Related]
6. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902
[TBL] [Abstract][Full Text] [Related]
7. Human pituitary somatotroph adenoma and prolactinoma: an ultrastructural and immunoelectron microscopical study.
Zhou XJ; Zhang TH; Yu YQ; Wang FA
J Tongji Med Univ; 1990; 10(2):83-7. PubMed ID: 2213957
[TBL] [Abstract][Full Text] [Related]
8. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
Buurman H; Saeger W
Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
[TBL] [Abstract][Full Text] [Related]
9. Annulate lamellae in prolactin-secreting pituitary adenomas.
Mori H; Mori S; Saitoh Y; Koizumi K; Aono T
Acta Neuropathol; 1983; 61(1):10-4. PubMed ID: 6624383
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.
Larouche V; Correa JA; Cassidy P; Beauregard C; Garfield N; Rivera J
Pituitary; 2016 Apr; 19(2):202-9. PubMed ID: 26700946
[TBL] [Abstract][Full Text] [Related]
11. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay.
Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL
J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Management Challenges in Prolactinomas.
Vroonen L; Daly AF; Beckers A
Neuroendocrinology; 2019; 109(1):20-27. PubMed ID: 30731464
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
14. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: a pseudotumoral disease.
Peillon F; Dupuy M; Li JY; Kujas M; Vincens M; Mowszowicz I; Derome P
J Clin Endocrinol Metab; 1991 Nov; 73(5):1008-15. PubMed ID: 1939514
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
[TBL] [Abstract][Full Text] [Related]
16. Age-related and gender-related occurrence of pituitary adenomas.
Mindermann T; Wilson CB
Clin Endocrinol (Oxf); 1994 Sep; 41(3):359-64. PubMed ID: 7893282
[TBL] [Abstract][Full Text] [Related]
17. [Prolactin producing adenoma].
Tamaki N; Yonezawa K
Nihon Rinsho; 1993 Oct; 51(10):2685-90. PubMed ID: 8254940
[TBL] [Abstract][Full Text] [Related]
18. Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina.
Day PF; Loto MG; Glerean M; Picasso MF; Lovazzano S; Giunta DH
Arch Endocrinol Metab; 2016; 60(6):554-561. PubMed ID: 27982201
[TBL] [Abstract][Full Text] [Related]
19. Gender-related differences in prolactin secretion in pituitary prolactinomas.
Nishioka H; Haraoka J; Akada K; Azuma S
Neuroradiology; 2002 May; 44(5):407-10. PubMed ID: 12012125
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.
Dogansen SC; Yalin GY; Tanrikulu S; Tekin S; Nizam N; Bilgic B; Sencer S; Yarman S
Pituitary; 2018 Aug; 21(4):347-354. PubMed ID: 29460202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
